Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III)

N Engl J Med. 1985 Jan 3;312(1):1-4. doi: 10.1056/NEJM198501033120101.

Abstract

Infection with human T-cell lymphotropic virus III (HTLV-III) is closely linked to the acquired immunodeficiency syndrome (AIDS). We evaluated the risk of nosocomial infection with HTLV-III by testing for antibodies to HTLV-III among hospital employees, including victims of needle-stick exposure, endoscopists, pathologists, and laboratory workers. Assays for antibody against the virus were performed by enzyme-linked immunosorbent assay and electrophoretic (Western blot) techniques. Although all 22 of our patients with AIDS and 6 of 7 with AIDS-related complex were found to have antibodies to HTLV-III when both assays were employed, none of the 85 employees with nosocomial exposure to specimens from patients with AIDS were positive for HTLV-III antibody. These studies must be regarded as preliminary, but they suggest that when current hospital isolation procedures are employed, the risk of nosocomial transmission of HTLV-III is low.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Accidents, Occupational
  • Acquired Immunodeficiency Syndrome / transmission*
  • Antibodies, Viral / analysis
  • Boston
  • Cross Infection / transmission*
  • Deltaretrovirus / immunology
  • Electrophoresis
  • Endoscopy
  • Enzyme-Linked Immunosorbent Assay
  • Hospital Bed Capacity, 300 to 499
  • Hospital Bed Capacity, 500 and over
  • Humans
  • Male
  • Needles
  • New York
  • Pathology
  • Personnel, Hospital*
  • Punctures
  • Research Personnel
  • Risk

Substances

  • Antibodies, Viral